Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 136 AL 150

Correlation between MMP-3-1171 5A/6A polymorphism and the risk of Alzheimer's disease: A meta-analysis

Wang Y, Zhu S, Ma Y, Chen X, Zhou M.

Medicine (Baltimore). 2026 Sep 11;105(37):e50560. doi: 10.1097/MD.0000000000050560.

Efficacy of Brexpiprazole on Neuropsychiatric Symptoms and Impact on Caregivers: Pooled Neuropsychiatric Inventory (NPI) Analysis in Patients With Agitation Associated With Dementia due to Alzheimer's Disease

Grossberg GT, Sabbagh MN, Chumki SR, Wang D, Such P, Zhang Z, Palma AM, Cummings JL.

J Geriatr Psychiatry Neurol. 2026 Sep;39(5):589-601. doi: 10.1177/08919887251407124. Epub 2025 Dec 24.

The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review

Moore GJ, Bose N, Henter ID, Manji HK.

JAMA Psychiatry. 2026 Sep 1;83(9):976-986. doi: 10.1001/jamapsychiatry.2026.1296.

Cannabinoids Treatment for Agitation in Alzheimer's Disease: A Systematic Review and Meta-Analysis With Bayesian and Sequential Trial Analyses

da Silva AMP, de Siqueira Lima DV Jr, Figueiroa Souza R, Lopes VHP, Januario Campos Cardoso L, Ornelas Pinto EL, Gonçalves OR, Braga C, Cal H, Haddad DS, Vasconcelos SMM, Duarte FS, Perry G, Anghinah R.

Am J Geriatr Psychiatry. 2026 Sep;34(9):1167-1183. doi: 10.1016/j.jagp.2026.05.016. Epub 2026 May 29.

Stage-dependent relationship between sleep duration and cortical tau deposition in cognitively impaired individuals: A cross-sectional study

Zheng Y, Kang L, Yang X, Zhou R, Chen H, Wang W, Xu X, Xu W, Liu J, Li B, Deng Y.

J Alzheimers Dis. 2026 Aug;112(4):1931-1944. doi: 10.1177/13872877261462419. Epub 2026 Jul 1.

Alzheimer's disease and nutrition: Focus on the impact of hyperhomocysteinemia

Clément G, Hansmannel F, Hopes L, Bossenmeyer-Pourié C, Renaud M.

J Alzheimers Dis. 2026 Sep;113(2):543-560. doi: 10.1177/13872877261471813. Epub 2026 Aug 1.

Transcriptome-wide association analysis of Alzheimer's disease: construction and clinical validation of transcriptomic risk scores

Zhang PF, Juan Z, Han J, Wang Y, Zhu T, Pang D, Zheng X, Lu Z.

Eur Arch Psychiatry Clin Neurosci. 2026 Oct;276(7):3765-3775. doi: 10.1007/s00406-026-02338-3. Epub 2026 Aug 17.

A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias

Dubbelman MA, Hill-Jarrett TG, Chapman S, Alves Andrade Dos Santos G, Azar M, Babulal GM, Bell TR, Bernard MA, Boza-Calvo C, Briggs AQ, Bubu OM, Cuevas HE, Dowling NM, Esiaka DK, Fausto BA, de Oliveira FF, Franz CE, Furlano JA, Gonzalez-Corona C, Guest MA, Gupta VB, Gupta VK, Jackson D, Joyce JL, Kann MR, Kremen WS, Lee A, Martinez JE, Masurkar AV, McLin MA, Resende EPF, Rahemi Z, Renfro BC, Aliberti MJR, Shagalow S, Slachevsky A, Talarico JNS, Trani JF, Van Hulle C, Waltrip L, Wandera SO, Windon CC, Yassuda MS, Moretti DV, Kuhn E, Butterbrod E, Gifford KA, Sikkes SAM, Castilhos RM, Nosheny R, Stites SD; a collaboration of the Alzheimer's Association International Society to Advance Alzheimer's Research and Therapy Subjective Cognitive Decline and Diversity and Disparities Professional Interest Areas.

Alzheimers Dement. 2026 Sep;22(9):e71779. doi: 10.1002/alz.71779.

Targeted Treatment of Agitation in Alzheimer's Dementia: Prioritizing Function and Safety Over Sedation and Other Serious Harms

Tariot PN, Citrome L, Clevenger CK, Jackson WC, Montano CB, Patel A, Porsteinsson AP, Sabbagh M.

Prim Care Companion CNS Disord. 2026 Sep 22;28(5):haadachi2603. doi: 10.4088/PCC.haadachi2603.

A scoping review of frontal cortex tDCS on neuropsychological functioning in older adults with mild cognitive impairment and Alzheimer's Clinical Syndrome

Helphrey JH, Hart J, McClintock SM, Peters ME, Thakkar VJ, LoBue C.

Int Rev Psychiatry. 2026 Sep;38(6):720-736. doi: 10.1080/09540261.2026.2647921. Epub 2026 Apr 6.

Predicting future cognitive impairment in preclinical Alzheimer's disease using amyloid PET and MRI: A multisite machine learning study

Yang B, Earnest T, Bilgel M, Albert MS, Johnson SC, Davatzikos C, Erus G, Masters CL, Resnick SM, Miller MI, Bakker A, Morris JC, Benzinger TLS, Gordon BA, Sotiras A; Alzheimer’s Disease Neuroimaging Initiative; Preclinical Alzheimer’s Disease Consortium.

Neurobiol Aging. 2026 Sep;165:8-23. doi: 10.1016/j.neurobiolaging.2026.04.005. Epub 2026 Apr 19.

Mechanistic insights into mesenchymal stem cell therapy for cognitive impairments in Alzheimer's disease models: a systematic review and meta-analysis

Kariminejad-Farsangi H, Kariminejad-Farsangi H, Mir Y, Sheibani V, Joushi S.

Mol Cell Biochem. 2026 Aug;481(8):3267-3287. doi: 10.1007/s11010-026-05576-0. Epub 2026 May 21.

The role of organochlorine pesticides as environmental factors in Alzheimer's disease in human studies: A systematic review and meta-analysis

Ghaedrahmat Z, Almasi F, Shamsi Goushki J, Moghiseh Z.

J Alzheimers Dis. 2026 Sep;113(1):36-48. doi: 10.1177/13872877261465828. Epub 2026 Jul 7.

Alzheimer's disease and related dementias in South and Southeast Asia: a systematic review and meta-analysis of epidemiology and associated factors

Rahman M, Saha T, Nayeem MAJ, Tabassum A, Abdullah I, Sultana S, Jahan I, Hasan I, Hayat S, Papri N, Mohammad QD, Islam Z.

BMJ Open. 2026 Sep 23;16(9):e118140. doi: 10.1136/bmjopen-2026-118140.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias